DYRK2 and cancer: In conclusion, we found that certain cancer-related point mutations and the non-cancer-related catalytically inactive Dyrk2-mutant cause a disassembly of the kinase core module revealed by the both complementary interaction approaches AP–MS and BioID–MS.